Actively Recruiting
Extension Study Evaluating Long-Term Safety and Effectiveness of Afimkibart in Adults with Rheumatoid Arthritis Previously Treated in Clinical Trials
Led by Hoffmann-La Roche · Updated on 2026-10-16
120
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the long-term safety and effectiveness of Afimkibart also called RO7790121 in adults with moderate to severe Rheumatoid Arthritis who have not responded well or are intolerant to tumor necrosis factor TNF andor Janus kinase JAK inhibitors. This study focuses on participants who have already been treated with Afimkibart in earlier clinical trials. The goal is to understand how Afimkibart works over an extended period in this patient group. Participants will receive Afimkibart as a subcutaneous injection according to the study protocol. The study uses a randomized, parallel design with two experimental groups both receiving Afimkibart. The treatment lasts up to six years, allowing researchers to gather long-term data on safety and disease control. There are no placebo or comparator groups in this extension study. During the study, participants will be regularly assessed for adverse events and improvements in Rheumatoid Arthritis symptoms using measures like the American College of Rheumatology improvement criteria and Disease Activity Scores. Blood tests will monitor Afimkibart levels and antibody responses. The study also tracks clinical remission and low disease activity over time. Participants are monitored closely throughout the study to evaluate treatment effects and safety for up to six years.
CONDITIONS
Brief Title
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Research Team
R
Reference Study ID Number: WA46440 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here